These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9333124)

  • 21. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
    Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells.
    Jiang S; Wu MW; Sternberg P; Jones DP
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):645-55. PubMed ID: 10711676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL
    Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death.
    Villalba M; Kasibhatla S; Genestier L; Mahboubi A; Green DR; Altman A
    J Immunol; 1999 Dec; 163(11):5813-9. PubMed ID: 10570264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.
    Zipp F; Martin R; Lichtenfels R; Roth W; Dichgans J; Krammer PH; Weller M
    J Immunol; 1997 Sep; 159(5):2108-15. PubMed ID: 9278296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
    Kaser A; Nagata S; Tilg H
    Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
    Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
    J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation.
    Mastro AM; Gay CV; Welch DR; Donahue HJ; Jewell J; Mercer R; DiGirolamo D; Chislock EM; Guttridge K
    J Cell Biochem; 2004 Feb; 91(2):265-76. PubMed ID: 14743387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century.
    Pinti M; Troiano L; Nasi M; Bellodi C; Ferraresi R; Mussi C; Salvioli G; Cossarizza A
    Circulation; 2004 Nov; 110(19):3108-14. PubMed ID: 15505087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro.
    Badie B; Schartner J; Vorpahl J; Preston K
    Exp Neurol; 2000 Apr; 162(2):290-6. PubMed ID: 10739635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of survival in osteoblasts from postmenopausal women.
    García-Moreno C; Catalán MP; Ortiz A; Alvarez L; De la Piedra C
    Bone; 2004 Jul; 35(1):170-7. PubMed ID: 15207753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells.
    Petak I; Tillman DM; Harwood FG; Mihalik R; Houghton JA
    Cancer Res; 2000 May; 60(10):2643-50. PubMed ID: 10825136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis.
    Caricchio R; Reap EA; Cohen PL
    J Immunol; 1998 Jul; 161(1):241-51. PubMed ID: 9647230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas.
    Legembre P; Moreau P; Daburon S; Moreau JF; Taupin JL
    Cell Death Differ; 2002 Mar; 9(3):329-39. PubMed ID: 11859415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human retinal pigment epithelial cell-induced apoptosis in activated T cells.
    Jørgensen A; Wiencke AK; la Cour M; Kaestel CG; Madsen HO; Hamann S; Lui GM; Scherfig E; Prause JU; Svejgaard A; Odum N; Nissen MH; Röpke C
    Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1590-9. PubMed ID: 9699548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.